Initiation and intensification of insulin therapy in patients with type 2 diabetes mellitus: a budget impact analysis

E. V. Biryukova; V. I. Ignat’eva

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology
Farmakoèkonomika

eng | рус

User

ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

Advanced search

Archives

Download this PDF file

Fullscreen

For citation:

Biryukova E.V., Ignat’eva V.I. Initiation and intensification of insulin therapy in patients with type 2 diabetes mellitus: a budget impact analysis. FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology. 2017;10(3):3-10. (In Russ.) https://doi.org/10.17749/2070-4909.2017.10.3.003-010

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)

Editor-in-chief

Vitaly V. Omelyanovskiy

Article Tools

How to cite item

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

E. V. Biryukova
A. I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of the Russian Federation
Russian Federation

Biryukova Elena Valer’evna – MD, Professor, the Department of endocrinology and diabetology at the Moscow State University of Medicine and Dentistry.

Address: ul. Delegatskaya, 20-1, Moscow, 127473

V. I. Ignat’eva
The Russian Presidential Academy of National Economy and Public Administration

Ignatyeva Viktoria Igorevna – Researcher at the Center for Health Technology Assessment

Address: Vernadskogo prospect, 82, Moscow, Russia, 119571.

Notifications

Username
Password
	Remember me

User

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

For citation:

Cookies policy